Journal
BREAST CANCER RESEARCH
Volume 13, Issue 4, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/bcr2889
Keywords
-
Categories
Funding
- Breast Cancer Campaign
- Dr Hadwen Trust for Humane Research
- Lord Dowding Fund for Humane Research
Ask authors/readers for more resources
Breast cancer is a complex and heterogeneous disease. Gene expression profiling has contributed significantly to our understanding of this heterogeneity at a molecular level, refining taxonomy based on simple measures such as histological type, tumour grade, lymph node status and the presence of predictive markers like oestrogen receptor and human epidermal growth factor receptor 2 (HER2) to a more sophisticated classification comprising luminal A, luminal B, basal-like, HER2-positive and normal subgroups. In the laboratory, breast cancer is often modelled using established cell lines. In the present review we discuss some of the issues surrounding the use of breast cancer cell lines as experimental models, in light of these revised clinical classifications, and put forward suggestions for improving their use in translational breast cancer research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available